Bruker Co. (NASDAQ:BRKR – Free Report) – Stock analysts at Zacks Research upped their FY2027 EPS estimates for shares of Bruker in a report issued on Tuesday, March 11th. Zacks Research analyst R. Department now forecasts that the medical research company will post earnings per share of $3.61 for the year, up from their prior estimate of $3.60. The consensus estimate for Bruker’s current full-year earnings is $2.69 per share.
Bruker (NASDAQ:BRKR – Get Free Report) last posted its earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%.
Check Out Our Latest Stock Analysis on Bruker
Bruker Stock Performance
NASDAQ BRKR opened at $45.97 on Thursday. The firm has a 50-day moving average of $53.93 and a 200-day moving average of $58.57. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.77 and a current ratio of 1.60. The stock has a market cap of $6.97 billion, a PE ratio of 60.49, a P/E/G ratio of 2.16 and a beta of 1.18. Bruker has a 52-week low of $44.11 and a 52-week high of $94.86.
Bruker Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, March 28th. Investors of record on Monday, March 17th will be issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.44%. The ex-dividend date is Monday, March 17th. Bruker’s dividend payout ratio (DPR) is presently 26.32%.
Institutional Investors Weigh In On Bruker
Hedge funds and other institutional investors have recently made changes to their positions in the stock. True Wealth Design LLC grew its holdings in shares of Bruker by 4,636.4% during the 3rd quarter. True Wealth Design LLC now owns 521 shares of the medical research company’s stock valued at $36,000 after purchasing an additional 510 shares during the last quarter. Eagle Bay Advisors LLC grew its holdings in shares of Bruker by 2,324.1% during the 4th quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company’s stock valued at $41,000 after purchasing an additional 674 shares during the last quarter. UMB Bank n.a. grew its holdings in shares of Bruker by 37.5% during the 4th quarter. UMB Bank n.a. now owns 909 shares of the medical research company’s stock valued at $53,000 after purchasing an additional 248 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of Bruker by 47.5% during the 4th quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company’s stock valued at $75,000 after purchasing an additional 412 shares during the last quarter. Finally, Quadrant Capital Group LLC grew its holdings in shares of Bruker by 18.2% during the 4th quarter. Quadrant Capital Group LLC now owns 1,273 shares of the medical research company’s stock valued at $75,000 after purchasing an additional 196 shares during the last quarter. 79.52% of the stock is owned by institutional investors.
About Bruker
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
Featured Stories
- Five stocks we like better than Bruker
- What is a Bond Market Holiday? How to Invest and Trade
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- 3 REITs to Buy and Hold for the Long Term
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- The 3 Best Fintech Stocks to Buy Now
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.